These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24000665)

  • 1. [Neuroendocrine tumors of digestive system: morphologic spectrum and cell proliferation (Ki67 index)].
    Delektorskaia VV; Kushliskiĭ NE
    Vestn Ross Akad Med Nauk; 2013; (5):28-37. PubMed ID: 24000665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
    Özaslan E; Demir S; Karaca H; Güven K
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathology of neuroendocrine neoplasms].
    Anlauf M; Gerlach P; Schott M; Raffel A; Krausch M; Knoefel WT; Pavel M; Klöppel G
    Chirurg; 2011 Jul; 82(7):567-73. PubMed ID: 21487814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ki67 and neuroendocrine tumors].
    Couvelard A
    Ann Pathol; 2011 Nov; 31(5 Suppl):S55-6. PubMed ID: 22054461
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease.
    Miller HC; Drymousis P; Flora R; Goldin R; Spalding D; Frilling A
    World J Surg; 2014 Jun; 38(6):1353-61. PubMed ID: 24493070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
    Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
    Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study].
    Zhang MH; Liu YH; Luo XL; Lin XT; Zhuang HG
    Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):448-51. PubMed ID: 22932454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
    Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P
    Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic Neuroendocrine Tumors.
    Salaria SN; Shi C
    Surg Pathol Clin; 2016 Dec; 9(4):595-617. PubMed ID: 27926362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced digestive neuroendocrine tumors: metastatic pattern is an independent factor affecting clinical outcome.
    Panzuto F; Merola E; Rinzivillo M; Partelli S; Campana D; Iannicelli E; Pilozzi E; Mercantini P; Rossi M; Capurso G; Scarpa A; Cascinu S; Tomassetti P; Falconi M; Delle Fave G
    Pancreas; 2014 Mar; 43(2):212-8. PubMed ID: 24518498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report.
    Rindi G; Bordi C; La Rosa S; Solcia E; Delle Fave G; ;
    Dig Liver Dis; 2011 Mar; 43 Suppl 4():S356-60. PubMed ID: 21459341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of NET: Current concepts and new developments.
    Schmitt AM; Blank A; Marinoni I; Komminoth P; Perren A
    Best Pract Res Clin Endocrinol Metab; 2016 Jan; 30(1):33-43. PubMed ID: 26971842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53, KI-67, CD117 expression in gastrointestinal and pancreatic neuroendocrine tumours and evaluation of their correlation with clinicopathological and prognostic parameters.
    Kımıloğlu Şahan E; Erdoğan N; Ulusoy İ; Samet E; Akyıldız İğdem A; Gönüllü D
    Turk J Gastroenterol; 2015 Mar; 26(2):104-11. PubMed ID: 25835106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-evaluation of cases with gastroenteropancreatic neuroendocrine tumors between 2004 and 2012 according to the 2010 criteria.
    Ozkara S; Aker F; Yesil A; Senates E; Canbey C; Yitik A; Gonen C
    Hepatogastroenterology; 2013 Oct; 60(127):1665-72. PubMed ID: 24627925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask.
    Albertelli M; Grillo F; Lo Calzo F; Puliani G; Rainone C; Colao AAL; Faggiano A;
    Front Endocrinol (Lausanne); 2021; 12():680305. PubMed ID: 33967966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
    Grabowski P; Schrader J; Wagner J; Hörsch D; Arnold R; Arnold CN; Georgieva I; Stein H; Zeitz M; Daniel PT; Sturm I
    Clin Cancer Res; 2008 Nov; 14(22):7378-84. PubMed ID: 19010853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
    Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
    [No Abstract]   [Full Text] [Related]  

  • 18. [Classification of gastro-entero-pancreatic neuroendocrine tumors].
    Perren A; Schmitt A; Komminoth P; Pavel M
    Radiologe; 2009 Mar; 49(3):198-205. PubMed ID: 19224191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G; La Rosa S
    Virchows Arch; 2018 Mar; 472(3):341-349. PubMed ID: 29134440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trends in gastroenteropancreatic neuroendocrine tumors].
    Kajiwara H; Osamura Y
    Nihon Geka Gakkai Zasshi; 2008 May; 109(3):123-7. PubMed ID: 18536314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.